These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18164899)

  • 1. [A rare case of nifedipine bezoar].
    Jarry J; Sassoust G
    Presse Med; 2008 Mar; 37(3 Pt 1):428-30. PubMed ID: 18164899
    [No Abstract]   [Full Text] [Related]  

  • 2. Unexpected intra-operative diagnosis of a large cystic phaeochromocytoma and secondary nifedipine pharmacobezoar.
    Ginther DN; Kriegler S; Kanthan R; Shaw JM
    S Afr J Surg; 2012 Jul; 50(3):98-9. PubMed ID: 22856448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-release nifedipine bezoar identified one year after discontinuation.
    Niezabitowski LM; Nguyen BN; Gums JG
    Ann Pharmacother; 2000; 34(7-8):862-4. PubMed ID: 10928396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged QT interval and ventricular fibrillation after treatment with sublingual nifedipine for malignant hypertension.
    Peters FP; de Zwaan C; Kho L
    Arch Intern Med; 1997 Dec 8-22; 157(22):2665-6. PubMed ID: 9531240
    [No Abstract]   [Full Text] [Related]  

  • 5. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 6. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with nifedipine retard: increasing doses as a therapeutic method].
    Lobos Berajano JM; Lahoz Rallo F; Seguido Aliaga P; Castellanos Maroto J; Robles Pérez R
    Rev Clin Esp; 1989 Jan; 184(1):47-9. PubMed ID: 2704870
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 9. [A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?].
    Wenzel UO; Pfalzer B; Meinertz T; Stahl RA
    Internist (Berl); 1999 Feb; 40(2):205-9. PubMed ID: 10097979
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term efficacy and adverse event of nifedipine sustained-release tablets for cyclosporin A-induced hypertension in patients with psoriasis.
    Nakayama J; Koga T; Furue M
    Eur J Dermatol; 1998 Dec; 8(8):563-8. PubMed ID: 9889429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium antagonists--much noise about nothing?].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical features and up-to-date therapy of hypertensive emergencies].
    Meyer FP
    Dtsch Med Wochenschr; 2004 Apr; 129(14):768; author reply 768-9. PubMed ID: 15042498
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium antagonists in coronary artery disease and hypertension. Time for reevaluation?
    Yusuf S
    Circulation; 1995 Sep; 92(5):1079-82. PubMed ID: 7648648
    [No Abstract]   [Full Text] [Related]  

  • 15. Another report of adverse reactions to immediate-release nifedipine.
    Fami MJ; Ho NT; Mason CM
    Pharmacotherapy; 1998; 18(5):1133-5. PubMed ID: 9758326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of calcium antagonists.
    Lichtlen PR
    Lancet; 1995 Oct; 346(8980):962. PubMed ID: 7564741
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA gives calcium channel blockers clean bill of health but warns of short-acting nifedipine hazards.
    Marwick C
    JAMA; 1996 Feb; 275(6):423-4. PubMed ID: 8627948
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-substitution of nifedipine slow-release preparations.
    Van Veenhuyzen D; Coetzee R
    S Afr Med J; 2002 Nov; 92(11):838, 840. PubMed ID: 12506575
    [No Abstract]   [Full Text] [Related]  

  • 19. Nifedipine-induced gingival overgrowth.
    Johnson RB
    Ann Pharmacother; 1997; 31(7-8):935. PubMed ID: 9220065
    [No Abstract]   [Full Text] [Related]  

  • 20. Case presentation. Initiation of gingival overgrowth by an increased daily dosage of nifedipine.
    Henderson JS; Guillot JL; Krolls SO; Parkel CO; Johnson RB
    Miss Dent Assoc J; 1994; 50(3):12-3. PubMed ID: 9569836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.